Delvin Formulations Private Limited, a amalgamated private limited company, was established on 24 July 2009 in Kanchipuram, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100TN2009PTC072376. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.25 Cr and a paid-up capital of ₹2.28 Cr.
It upholds a compliant status. Employing 219 professional, Its leadership includes Ayyavu Rajavel (Alternate Director), Shanmugam Muthusamy (Director), Jaganathan Jayaseelan (Director). It holds no open charges and ₹27.37 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at No 5/A5, 3Rd Cross Street Sipcot It Park, Siruseri India, Chingleput, Tamil Nadu, 603103.
U24100TN2009PTC072376
072376
24 July 2009
₹3.25 Cr
₹2.28 Cr
Roc Chennai
Unlisted
Amalgamated
Explore comprehensive insights into Delvin Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ayyavu Rajavel | Alternate Director | 13 Aug 2009 | Current |
| Shanmugam Muthusamy | Director | 24 Jul 2009 | Current |
| Jaganathan Jayaseelan | Director | 24 Jul 2009 | Current |
| Bernice Sugirtha | Director | 14 Dec 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Delvin Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.51% increase. The company also saw a substantial improvement in profitability, with a 67.94% increase in profit. The company's net worth Soared by an impressive increase of 100.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Delvin Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹273,694,600.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2022 | Others | ₹10.44 Cr | Satisfied |
| 20 May 2019 | Others | ₹0.09 M | Satisfied |
| 14 Feb 2019 | Others | ₹2.35 M | Satisfied |
| 01 Jun 2018 | Others | ₹2.31 M | Satisfied |
| 30 Jan 2017 | Hdfc Bank Limited | ₹11.45 Cr | Satisfied |
Explore comprehensive loan charge details -
Delvin Formulations has a workforce of 219 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Delvin Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delvin Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 20 May 2019 via Charge ID 100267035 with Others was fully satisfied on 20 May 2024. was recorded as a recent event.
A charge registered on 10 Oct 2022 via Charge ID 100624035 with Others was fully satisfied on 11 Oct 2023. was recorded as a recent event.
Progress on Delvin Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on Delvin Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai. was documented.
A charge registered on 14 Feb 2019 via Charge ID 100243273 with Others was fully satisfied on 15 Mar 2023. was recorded as a recent event.
Progress on A charge registered on 01 Jun 2018 via Charge ID 100184732 with Others was fully satisfied on 15 Mar 2023. was documented.
The CIN of Delvin Formulations Private Limited is U24100TN2009PTC072376.
Delvin Formulations Private Limited is headquartered at No 5/A5, 3Rd Cross Street Sipcot It Park, Siruseri India, Chingleput, Tamil Nadu, 603103.
Delvin Formulations Private Limited was incorporated on 24 July 2009.
The current directors of Delvin Formulations Private Limited are
The primary industry of Delvin Formulations Private Limited is Trade.
Delvin Formulations Private Limited is unlisted.
The authorized capital of Delvin Formulations Private Limited is ₹3.25 Cr, and the paid-up capital is ₹2.28 Cr.
The compliance status of Delvin Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX